Browsing Tag
Amylyx Pharmaceuticals
4 posts
Amylyx (Nasdaq: AMLX) upsizes offering to $500m as avexitide advances
The biotechnology company is selling 14.09 million shares at $35.50 after avexitide cut severe hypoglycemic events by 55% in pivotal Phase 3 testing.
Amylyx Pharmaceuticals resumes AMX0114 clinical trials for ALS after FDA clears path
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has announced that the U.S. Food and Drug Administration (FDA) has lifted the…
Amylyx Pharmaceuticals’ AMX0035 misses primary and secondary endpoints in ALS study
Cambridge, Massachusetts-based Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a key player in the pharmaceutical industry, announced today the top-line…
Amylyx Pharmaceuticals gets RELYVRIO FDA approval for ALS
RELYVRIO FDA approval for ALS : Amylyx Pharmaceuticals has secured approval for RELYVRIO (sodium phenylbutyrate and taurursodiol) from…